促销时间表 Phoenix Biotech Acquisition Corp.
先进的时间表
简单图表
关于公司
Phoenix Biotech Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It engages in identifying and acquiring a business that focuses on the healthcare or healthcare related industries in the United States and Europe. Phoenix Biotech Acquisition Corp. was incorporated in 2021 and is based in Oakland, California.
每日价格变化: |
0% (4.9) |
每周价格变化: |
0% (4.9) |
每月价格变化: |
0% (4.9) |
3个月内价格变化: |
0% (4.9) |
六个月内的价格变化: |
0% (4.9) |
每年价格变化: |
-55.45% (11) |
3年内价格变化: |
-50.55% (9.91) |
5年内价格变化: |
0% (4.9) |
10年价格变化: |
0% (4.9) |
年初以来价格变化: |
0% (4.9) |
|
低估
姓名 |
意义 |
年级 |
P/S |
719.84 |
1 |
P/BV |
74.31 |
1 |
P/E |
0 |
0 |
EV/EBITDA |
-31.98 |
0 |
全部的: |
|
0.625 |
|
效率
姓名 |
意义 |
年级 |
ROA, % |
-0.6004 |
0 |
ROE, % |
-0.7706 |
0 |
全部的: |
|
0 |
|
|
股息
姓名 |
意义 |
年级 |
Div yield, % |
0 |
0 |
DSI |
0 |
0 |
全部的: |
|
0 |
|
责任
姓名 |
意义 |
年级 |
Debt/EBITDA |
-0.114 |
10 |
全部的: |
|
10 |
|
成长冲动
姓名 |
意义 |
年级 |
盈利能力 Revenue, % |
0 |
0 |
盈利能力 Ebitda, % |
1629.61 |
10 |
盈利能力 EPS, % |
2336.5 |
10 |
全部的: |
|
8 |
|
导师 |
职称 |
支付 |
出生年份 |
Mr. Christopher B. Ehrlich M.B.A. |
CEO & Director |
N/A |
1970 (55 年) |
Dr. Douglas Carl Fisher M.B.A., M.D. |
President |
N/A |
1976 (49 年) |
Mr. Daniel E. Geffken M.B.A. |
Chief Financial Officer |
N/A |
1957 (68 年) |